Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Senate Judiciary advances bill to classify gabapentin as Schedule V
Summary
The Senate Judiciary Committee heard testimony supporting House Bill 41, which would classify gabapentin as a Schedule V controlled substance to enable tracking of dispensing and aid toxicology in multi‑drug DUI and post‑mortem cases; the committee later concurred on the bill.
Representative Curtis Schomer introduced House Bill 41 to classify gabapentin as a Schedule V controlled substance, saying the change is a 'safety bill' that would give law enforcement and toxicologists better tools to identify and respond to misuse. "House bill 41 makes gabapentin a schedule 5 drug," Schomer told the committee, and he urged members to support the measure.
Beth Smalley, lead scientist and supervisor of the toxicology and breath alcohol sections at the Montana Forensic Science Division, testified that the division has seen a significant rise in gabapentin detections after adopting improved testing methods. "It is enough of a concern that 7 other states have…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
